Eszopiclone for insomnia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eszopiclone for insomnia

Published:2018-10-10 Issue:10 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rösner Susanne¹,Englbrecht Christian¹,Wehrle Renate²,Hajak Göran³,Soyka Michael⁴

Affiliation:

1. Forel Klinik; Islikonerstrasse 5 Ellikon an der Thur Switzerland 8548

2. EasyCap; Steingrabenstr. 14 Herrsching Germany 82211

3. Social Foundation Bamberg; Bamberg Germany

4. University of Munich; Psychiatric Hospital; Nußbaumstr. 7 Munich Germany 80336

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010703.pub2/epdf/full

Reference230 articles.

1. A 12-week, randomised, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia;Ancoli-Israel;Sleep,2010

2. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder;Fava;Biological Psychiatry,2006

3. A randomised, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain;Goforth;Sleep,2014

4. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomised, double-blind, placebo-controlled study in adults with chronic insomnia;Krystal;Sleep,2003

5. A polysomnography study of eszopiclone in elderly patients with insomnia;McCall;Current Medical Research and Opinion,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches;Molecular Neurobiology;2024-08-05

2. SGLT2 inhibition, circulating proteins, and insomnia: A mendelian randomization study;Sleep Medicine;2024-07

3. Prognostic models for predicting insomnia treatment outcomes: A systematic review;Journal of Psychiatric Research;2024-02

4. Insomnia;Treatment of Psychiatric Disorders Among Older Adults;2024

5. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023;Journal of Sleep Research;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3